Loading clinical trials...
Loading clinical trials...
Phase II Trial on Efficacy of mTOR Inhibitor RAD001 as Maintenance Therapy for Patients Above 60 Years in Mantle Cell Lymphoma After First and Second Line Chemotherapy
Conditions
Interventions
everolimus
Locations
1
Germany
Klinikum Rechts Der Isar - Technische Universitaet Muenchen
Munich, Germany
Start Date
May 1, 2008
Primary Completion Date
May 1, 2011
Completion Date
September 1, 2014
Last Updated
December 17, 2012
NCT05139017
NCT07388563
NCT05529069
NCT06263491
NCT06337318
NCT07350863
Lead Sponsor
Technical University of Munich
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions